Studies have shown that CDC45 is a proliferation-associated antigen that may promote tumorigenesis and metastasis [35,36], and that CDC45 is overexpressed in several cancer-derived cell lines, including carcinoma-, sarcoma-, leukemia-, and lymphoma-derived cells [35]. This evidence concerns the gene CDC45 and carcinoma.